Navigen Inc - Company Review
SummaryNavigen Inc - Company Review
Summary
Navigen Inc (Navigen) is a drug discovery and development company which focuses on development of novel therapeutic technologies. Its portfolio of pipeline product includes D- Peptides and ARF6 inhibitors. The company is conducting ongoing programs to address various diseases such as human immunodeficiency virus (HIV), respiratory syncytial virus (RSV) and Ebola virus. Navigen’s another lead program, inhibition of ARF6, is a novel target for the control of vascular leak caused by variety of pathogens, including multi-drug resistant bacteria. The company sources early-stage technologies from academia and advance them in to IND-enabling studies using non-dilutive funding from grants, contracts, and corporate collaborations. Navigen is headquartered in Salt Lake City, Utah, the US.
This comprehensive company report of Navigen Inc provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.